| __timestamp | Dr. Reddy's Laboratories Limited | Opthea Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 38783000000 | 2652041 |
| Thursday, January 1, 2015 | 42585000000 | 2361587 |
| Friday, January 1, 2016 | 45702000000 | 4472869 |
| Sunday, January 1, 2017 | 46372000000 | 5030957 |
| Monday, January 1, 2018 | 46910000000 | 4988941 |
| Tuesday, January 1, 2019 | 48890000000 | 5196412 |
| Wednesday, January 1, 2020 | 50129000000 | 6652774 |
| Friday, January 1, 2021 | 54559000000 | 18418247 |
| Saturday, January 1, 2022 | 62081000000 | 24827066 |
| Sunday, January 1, 2023 | 105931000000 | 41896408 |
| Monday, January 1, 2024 | 77201000000 | 15488619 |
Igniting the spark of knowledge
In the ever-evolving pharmaceutical landscape, effective cost management is crucial. Dr. Reddy's Laboratories Limited and Opthea Limited, two prominent players, showcase contrasting strategies in managing Selling, General, and Administrative (SG&A) expenses over the past decade. From 2014 to 2023, Dr. Reddy's Laboratories consistently increased its SG&A expenses, peaking in 2023 with a staggering 105% rise from 2014. This reflects their aggressive expansion and market penetration strategies. In contrast, Opthea Limited, a smaller entity, exhibited a more conservative approach, with a modest 57% increase in the same period. This disparity highlights the diverse financial strategies within the pharmaceutical sector, where larger firms may leverage scale for growth, while smaller companies focus on sustainable development. As we look to 2024, these trends offer valuable insights into the financial health and strategic priorities of these industry leaders.
Selling, General, and Administrative Costs: Eli Lilly and Company vs Opthea Limited
Comparing SG&A Expenses: Sanofi vs Opthea Limited Trends and Insights
Cost Management Insights: SG&A Expenses for Gilead Sciences, Inc. and Opthea Limited
Operational Costs Compared: SG&A Analysis of Vertex Pharmaceuticals Incorporated and Opthea Limited
Comparing SG&A Expenses: Biogen Inc. vs Dr. Reddy's Laboratories Limited Trends and Insights
Genmab A/S and Opthea Limited: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for Dr. Reddy's Laboratories Limited and Xenon Pharmaceuticals Inc.
Operational Costs Compared: SG&A Analysis of Dr. Reddy's Laboratories Limited and Taro Pharmaceutical Industries Ltd.
Cost Management Insights: SG&A Expenses for Pharming Group N.V. and Opthea Limited
Comparing SG&A Expenses: Madrigal Pharmaceuticals, Inc. vs Opthea Limited Trends and Insights
Opthea Limited vs Alpine Immune Sciences, Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Opthea Limited and Mesoblast Limited